GPS Wealth Strategies Group’s Ionis Pharmaceuticals IONS Stock Holding History

GPS Wealth Strategies Group’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-119	Closed	-$7.79K	–	1053
2025 Q3	$7.79K	Hold	119	–	–	﹤0.01%	1148
2025 Q2	$4.7K	Hold	119	–	–	﹤0.01%	1223
2025 Q1	$3.59K	Hold	119	–	–	﹤0.01%	1227
2024 Q4	$4.16K	Hold	119	–	–	﹤0.01%	1126
2024 Q3	$4.77K	Hold	119	–	–	﹤0.01%	1114
2024 Q2	$5.67K	Sell	119 -65	-35%	-$2.67K	﹤0.01%	1042
2024 Q1	$7.98K	Sell	184 -14	-7%	-$667	﹤0.01%	906
2023 Q4	$10K	Hold	198	–	–	﹤0.01%	838
2023 Q3	$8.98K	Buy	198 +14	+8%	+$578	﹤0.01%	861
2023 Q2	$7.55K	Buy	184 +65	+55%	+$2.5K	﹤0.01%	896
2023 Q1	$4.25K	Buy	+119	New	+$4.47K	﹤0.01%	1005
2022 Q4	–	Sell	-119	Closed	-$5K	–	593
2022 Q3	$5K	Hold	119	–	–	﹤0.01%	888
2022 Q2	$4K	Hold	119	–	–	﹤0.01%	926
2022 Q1	$4K	Hold	119	–	–	﹤0.01%	892
2021 Q4	$4K	Hold	119	–	–	﹤0.01%	897
2021 Q3	$4K	Hold	119	–	–	﹤0.01%	870
2021 Q2	$5K	Hold	119	–	–	﹤0.01%	860
2021 Q1	$5K	Buy	+119	New	+$6.64K	﹤0.01%	771

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

GPS Wealth Strategies Group's IONS Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Ionis Pharmaceuticals (IONS) in Q4 2025, closing a stake of 119 shares — an estimated $7.79K sold.

GPS Wealth Strategies Group first reported a position in IONS in Q1 2021 and held it in 18 quarters. The position peaked at $10K in Q4 2023. 491 funds tracked by Wall St. Rank hold IONS as of Q4 2025.

GPS Wealth Strategies Group reported no remaining Ionis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
GPS Wealth Strategies Group sold 119 Ionis Pharmaceuticals shares in Q4 2025, an estimated $7.79K.
GPS Wealth Strategies Group first reported a position in Ionis Pharmaceuticals in Q1 2021 and held it in 18 quarters.
GPS Wealth Strategies Group's Ionis Pharmaceuticals position peaked at $10K in Q4 2023.
491 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.